Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil vs Fentanyl in Mastectomy
NCT04435925Completed
- Sponsor
- Udayana University
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of remifentanil in Breast disease (2 arms), sponsored by Udayana University. Primary endpoints: Serum Epinephrine Level at 24 hours, Serum Norepinephrine Level at 24 hours and 3 more. Started Jul 2020; status: completed.
02
Drugs
remifentanil
03
Conditions
Breast disease
Beyond the preview
Go deeper on NCT04435925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435925.